These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10596957)

  • 21. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The likelihood of diabetes based on the proposed definitions for impaired fasting glucose.
    Gao W; Dong Y; Nan H; Tuomilehto J; Qiao Q
    Diabetes Res Clin Pract; 2008 Jan; 79(1):151-5. PubMed ID: 17825938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New classification and criteria for diagnosis of diabetes mellitus. The Australasian Working Party on Diagnostic Criteria for Diabetes Mellitus.
    Colman PG; Thomas DW; Zimmet PZ; Welborn TA; Garcia-Webb P; Moore MP
    N Z Med J; 1999 Apr; 112(1086):139-41. PubMed ID: 10340693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
    Rush E; Crook N; Simmons D
    Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new classification of diabetes mellitus and IGT: a critical approach.
    Borch-Johnsen K
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S86-93. PubMed ID: 11460596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose and cardiovascular risk.
    Fuchs M; Hoekstra JB; Mudde AH
    Neth J Med; 2002 Jun; 60(5):192-9. PubMed ID: 12365474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New classification and diagnostic criteria for diabetes mellitus].
    López Stewart G
    Rev Med Chil; 1998 Jul; 126(7):833-7. PubMed ID: 9830777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired fasting glucose, diabetes mellitus and coronary risk factors.
    Bhuripanyo K; Ruangratanaamporn O; Mahanonda N; Leowattana W; Sriratanasathaavorn C; Chotinaiwattarakul C; Kangkagate C; Chaithiraphan S
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S146-52. PubMed ID: 11194006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creation of a low-risk reference group and reference interval of fasting venous plasma glucose.
    Jørgensen LG; Brandslund I; Hyltoft Petersen P; Stahl M; de Fine Olivarius N
    Clin Chem Lab Med; 2004; 42(7):817-23. PubMed ID: 15327018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Home blood sampling for plasma glucose assay in control of diabetes.
    Howe-Davies S; Holman RR; Phillips M; Turner RC
    Br Med J; 1978 Aug; 2(6137):596-8. PubMed ID: 568013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preanalytical issues related to routine and diagnostic glucose tests: Results from a survey in Spain.
    García-Del-Pino I; Bauça JM; Gómez C; Caballero A; Llopis MA; Ibarz M; Martínez D; Ventura M; Marzana I; Puente JJ; Segovia M; Salas P; Gómez-Rioja R
    Biochem Med (Zagreb); 2020 Feb; 30(1):010704. PubMed ID: 31839724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of MU for Glucose in Human Serum Using Bottom-up Approach.
    Tao Y; Dai H; Chen F; Zhou W; Shen L; Wang H; Ju S
    Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forgot to fast?: The importance on plasma glucose values.
    Hilton DJ; Welborn TA; O'Rourke PK; Reid CM
    Diabetes Care; 2002 Nov; 25(11):2112. PubMed ID: 12401774
    [No Abstract]   [Full Text] [Related]  

  • 36. A model for an uncertainty budget for preanalytical variables in clinical chemistry analyses.
    Rynning M; Wentzel-Larsen T; Bolann BJ
    Clin Chem; 2007 Jul; 53(7):1343-8. PubMed ID: 17495014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approved IFCC recommendation on reporting results for blood glucose (abbreviated).
    D'Orazio P; Burnett RW; Fogh-Andersen N; Jacobs E; Kuwa K; Külpmann WR; Larsson L; Lewenstam A; Maas AH; Mager G; Naskalski JW; Okorodudu AO;
    Clin Chem; 2005 Sep; 51(9):1573-6. PubMed ID: 16120945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disregarded Measurement Uncertainty Contributions and Their Magnitude in Measuring Plasma Glucose.
    Petersmann A; Macdonald R; Nauck M
    J Diabetes Sci Technol; 2022 Jan; 16(1):161-167. PubMed ID: 33218279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of glucose concentrations in rats: differences between glucose meter and plasma laboratory results.
    Weitgasser R; Davalli AM; Weir GC
    Diabetologia; 1999 Feb; 42(2):256. PubMed ID: 10064108
    [No Abstract]   [Full Text] [Related]  

  • 40. Reporting uncertainties in measurement: what approach should be followed?
    Hill R
    Australas Phys Eng Sci Med; 2013 Mar; 36(1):1-3. PubMed ID: 23504492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.